摘要
目的:探讨脑心综合征的发病机制、临床特点和预后。方法:对133例脑心综合征(cerebro-cardiac syndrom,CCS)患者作心肌酶谱检测,并对其病变部位及预后进行分析。结果:CCS发生率为48.12%,其中脑叶组为23.94%,基底节、丘脑组为72.22%,脑干卒中组为80.76%。表明脑干及基底节、丘脑组发生CCS的比率较脑叶组高(P<0.05)。发现脑出血组心肌酶比脑梗死组心肌酶有明显升高。结论:CCS常发生在脑干及基底节、丘脑卒中患者中,且脑出血组心肌损害较严重,应积极治疗,改善预后。
Objective：To explore the pathogenesis of cerebrocardic syndrome and its clinical manifestations and prognosis.Methods：One hundred and thirty-three patients with cerebrocardiac syndrome（CCS） underwent determination of the cardiac enzymes,and laboratory findings together with the lesion regions was analyzed for estimation of the prognosis.Results：The total morbidity of CCS was 48.12%,in which 23.94% of the cases was localized in the lobe of the brain,72.22% in basal ganglia or thalami and 80.76% in the brainstem.These findings suggested that CCS was more frequently seen in basal ganglia and thalamencephalon than the lobe of the brain（P〈0.05）.In addition,CCS patients complicated with cerebral hemorrhage tended to have elevated level of cardiac enzymes over those with cerebral infarction.Conclusion：CCS appears commonly involved in the brainstem,basal ganglia or thalamencephalon,and CCS patients with cerebral hemorrhage may be more serious cardiac damage and thus requires early and aggressive therapy for a better prognosis.
出处
《皖南医学院学报》
CAS
2012年第4期312-313,共2页
Journal of Wannan Medical College
关键词
急性脑血管病
脑心综合征
临床分析
acute cerebrovasular disease
cerebrocardic syndrome
clinical analysis
